{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:30:39Z","timestamp":1790256639224,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T00:00:00Z","timestamp":1587340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T00:00:00Z","timestamp":1587340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1038\/s41440-020-0440-2","type":"journal-article","created":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T09:03:24Z","timestamp":1587373404000},"page":"705-714","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Adherence to antihypertensive medication and its predictors among non-elderly adults in Japan"],"prefix":"10.1038","volume":"43","author":[{"given":"Shiori","family":"Nishimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiraku","family":"Kumamaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuaki","family":"Sawano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Kohsaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,20]]},"reference":[{"key":"440_CR1","unstructured":"World Health Organization. Global action plan for the prevention and cntrol of noncommunicable disease 2013\u20132020. http:\/\/www.who.int\/iris\/handle\/10665\/94384. Accessed 12 June 2019."},{"key":"440_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2147\/CEOR.S15619","volume":"3","author":"LD Esposti","year":"2011","unstructured":"Esposti LD, Saragoni S, Benemei S, Batacchi P, Geppetti P, di Bari M, et al. Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients. Clin Outcomes Res. 2011;3:47\u201354. https:\/\/doi.org\/10.2147\/CEOR.S15619","journal-title":"Clin Outcomes Res"},{"key":"440_CR3","doi-asserted-by":"publisher","unstructured":"Yang Q, Chang A, Ritchey MD, Loustalot F. Antihypertensive medication adherence and risk of cardiovascular disease among older adults: a population-based cohort study. J Am Heart Assoc. 2017;6. https:\/\/doi.org\/10.1161\/JAHA.117.006056","DOI":"10.1161\/JAHA.117.006056"},{"key":"440_CR4","doi-asserted-by":"publisher","unstructured":"Tinetti ME, Han L, McAvay GJ, Lee DSH, Peduzzi P, Dodson JA, et al. Anti-hypertensive medications and cardiovascular events in older adults with multiple chronic conditions. PLoS ONE. 2014;9. https:\/\/doi.org\/10.1371\/journal.pone.0090733","DOI":"10.1371\/journal.pone.0090733"},{"key":"440_CR5","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1161\/HYPERTENSIONAHA.115.06731","volume":"67","author":"S Kim","year":"2016","unstructured":"Kim S, Shin DW, Yun JM, Hwang Y, Park SK, Ko YJ, et al. Medication adherence and the risk of cardiovascular mortality and hospitalization among patients with newly prescribed antihypertensive medications. Hypertension. 2016;67:506\u201312. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.115.06731","journal-title":"Hypertension"},{"key":"440_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2016-014486","volume":"7","author":"HJ Lee","year":"2017","unstructured":"Lee HJ, Jang SI, Park EC. Effect of adherence to antihypertensive medication on stroke incidence in patients with hypertension: a population-based retrospective cohort study. BMJ Open. 2017;7:1\u20138. https:\/\/doi.org\/10.1136\/bmjopen-2016-014486","journal-title":"BMJ Open"},{"key":"440_CR7","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1001\/jamacardio.2018.4936","volume":"4","author":"F Rodriguez","year":"2019","unstructured":"Rodriguez F, Maron DJ, Knowles JW, Virani SS, Lin S, Heidenreich PA. Association of statin adherence with mortality in patients with atherosclerotic cardiovascular disease. JAMA Cardiol. 2019;4:206\u201313. https:\/\/doi.org\/10.1001\/jamacardio.2018.4936","journal-title":"JAMA Cardiol"},{"key":"440_CR8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1177\/1060028017743517","volume":"52","author":"P Simard","year":"2018","unstructured":"Simard P, Presse N, Roy L, Dorais M, White-Guay B, R\u00e4kel A, et al. Association between metformin adherence and all-cause mortality among new users of metformin: a nested case-control study. Ann Pharmacother. 2018;52:305\u201313. https:\/\/doi.org\/10.1177\/1060028017743517","journal-title":"Ann Pharmacother"},{"key":"440_CR9","unstructured":"World Health Organization. Adherence to long-term therapies: evidence for action; 2015. https:\/\/www.who.int\/chp\/knowledge\/publications\/adherence_report\/en\/. Accessed 3 April 2019."},{"key":"440_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/217047","volume":"2015","author":"WY Lam","year":"2015","unstructured":"Lam WY, Fresco P. Medication adherence measures: an overview. Biomed Res Int. 2015;2015:1\u201312. https:\/\/doi.org\/10.1155\/2015\/217047","journal-title":"Biomed Res Int"},{"key":"440_CR11","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1097\/HJH.0000000000001299","volume":"35","author":"I Hamdidouche","year":"2017","unstructured":"Hamdidouche I, Jullien V, Boutouyrie P, Billaud E, Azizi M, Laurent S. Drug adherence in hypertension: Frommethodological issues to cardiovascular outcomes. J Hypertens. 2017;35:1133\u201344. https:\/\/doi.org\/10.1097\/HJH.0000000000001299","journal-title":"J Hypertens"},{"key":"440_CR12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0197-2456(89)90126-8","volume":"10","author":"L Osterberg","year":"2005","unstructured":"Osterberg L, Blaschke T. Adherence to medication dosage schedules. Control Clin Trials. 2005;10:333\u20134. https:\/\/doi.org\/10.1016\/0197-2456(89)90126-8","journal-title":"Control Clin Trials"},{"key":"440_CR13","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1253\/circj.CJ-13-0847","volume":"77","author":"K Miura","year":"2013","unstructured":"Miura K, Nagai M, Ohkubo T. Epidemiology of hypertension in Japan. Circ J. 2013;77:2226\u201331. https:\/\/doi.org\/10.1253\/circj.CJ-13-0847","journal-title":"Circ J"},{"key":"440_CR14","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1161\/CIRCULATIONAHA.108.830299","volume":"120","author":"G Mazzaglia","year":"2009","unstructured":"Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation. 2009;120:1598\u2013605. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.830299","journal-title":"Circulation"},{"key":"440_CR15","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.ijcard.2016.06.263","volume":"220","author":"M Schulz","year":"2016","unstructured":"Schulz M, Krueger K, Schuessel K, Friedland K, Laufs U, Mueller WE, et al. Medication adherence and persistence according to different antihypertensive drug classes: a retrospective cohort study of 255,500 patients. Int J Cardiol. 2016;220:668\u201376. https:\/\/doi.org\/10.1016\/j.ijcard.2016.06.263","journal-title":"Int J Cardiol"},{"key":"440_CR16","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ijcard.2016.01.069","volume":"207","author":"A Calder\u00f3n-Larra\u00f1aga","year":"2016","unstructured":"Calder\u00f3n-Larra\u00f1aga A, Diaz E, Poblador-Plou B, Gimeno-Feliu LA, Abad-D\u00edez JM, Prados-Torres A. Non-adherence to antihypertensive medication: the role of mental and physical comorbidity. Int J Cardiol. 2016;207:310\u20136. https:\/\/doi.org\/10.1016\/j.ijcard.2016.01.069","journal-title":"Int J Cardiol"},{"key":"440_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.amjmed.2009.08.008","volume":"123","author":"O Friedman","year":"2010","unstructured":"Friedman O, McAlister FA, Yun L, Campbell NRC, Tu K. Antihypertensive drug persistence and compliance among newly treated elderly hypertensives in Ontario. Am J Med. 2010;123:173\u201381. https:\/\/doi.org\/10.1016\/j.amjmed.2009.08.008","journal-title":"Am J Med"},{"key":"440_CR18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jash.2012.02.004","volume":"6","author":"DY Ishisaka","year":"2012","unstructured":"Ishisaka DY, Jukes T, Romanelli RJ, Wong KS, Schiro TA. Disparities in adherence to and persistence with antihypertensive regimens: an exploratory analysis from a community-based provider network. J Am Soc Hypertens. 2012;6:201\u20139. https:\/\/doi.org\/10.1016\/j.jash.2012.02.004","journal-title":"J Am Soc Hypertens"},{"key":"440_CR19","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1524-6175.2007.07194.x","volume":"9","author":"BV Patel","year":"2007","unstructured":"Patel BV, Remigio-Baker RA, Mehta D, Thiebaud P, Frech-Tamas F, Preblick R. Effects of initial antihypertensive drug class on patient persistence and compliance in a usual-care setting in the United States. J Clin Hypertens. 2007;9:692\u2013700. https:\/\/doi.org\/10.1111\/j.1524-6175.2007.07194.x","journal-title":"J Clin Hypertens"},{"key":"440_CR20","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.ijcard.2012.04.060","volume":"167","author":"MCS Wong","year":"2012","unstructured":"Wong MCS, Tam WWS, Cheung CSK, Tong ELH, Sek ACH, Cheung NT, et al. Medication adherence to first-line antihypertensive drug class in a large Chinese population. Int J Cardiol. 2012;167:1438\u201342. https:\/\/doi.org\/10.1016\/j.ijcard.2012.04.060","journal-title":"Int J Cardiol"},{"key":"440_CR21","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ijcard.2014.12.064","volume":"182","author":"KQL Liu","year":"2014","unstructured":"Liu KQL, Griffiths SM, Wong MCS, Kang CD, Wang HHX, Li WTL, et al. Determinants of medication adherence and blood pressure control among hypertensive patients in Hong Kong: a cross-sectional study. Int J Cardiol. 2014;182:250\u20137. https:\/\/doi.org\/10.1016\/j.ijcard.2014.12.064","journal-title":"Int J Cardiol"},{"key":"440_CR22","unstructured":"Sakamoto H, Rahman M, Nomura S, Okamoto E, Koike S, Yasunaga H, et al. Japan health system review. World Health Organization. New Delhi, India: Regional Office for South-East Asia; 2018;8. p. 55."},{"key":"440_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jval.2018.08.006","volume":"22","author":"PP Pednekar","year":"2019","unstructured":"Pednekar PP, \u00c1gh T, Malmen\u00e4s M, Raval AD, Bennett BM, Borah BJ, et al. Methods for measuring multiple medication adherence: a systematic review\u2013Report of the ISPOR Medication Adherence and Persistence Special Interest Group. Value Heal. 2019;22:139\u201356. https:\/\/doi.org\/10.1016\/j.jval.2018.08.006","journal-title":"Value Heal"},{"key":"440_CR24","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1161\/CIRCULATIONAHA.108.768986","volume":"119","author":"PM Ho","year":"2009","unstructured":"Ho PM, Bryson CL, Rumsfeld JS. Medication adherence. Circulation. 2009;119:3028\u201335. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.768986","journal-title":"Circulation"},{"key":"440_CR25","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.18553\/jmcp.2018.24.11.1146","volume":"24","author":"H Kumamaru","year":"2018","unstructured":"Kumamaru H, Lee MP, Choudhry NK, Dong Y-H, Krumme AA, Khan N, et al. Using previous medication adherence to predict future adherence. J Manag Care Spec Pharm. 2018;24:1146\u201355. https:\/\/doi.org\/10.18553\/jmcp.2018.24.11.1146","journal-title":"J Manag Care Spec Pharm"},{"key":"440_CR26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41440-018-0127-0","volume":"42","author":"T Ishida","year":"2018","unstructured":"Ishida T, Oh A, Hiroi S, Shimasaki Y, Nishigaki N, Tsuchihashi T. Treatment patterns and adherence to antihypertensive combination therapies in Japan using a claims database. Hypertens Res. 2018;42:249\u201356. https:\/\/doi.org\/10.1038\/s41440-018-0127-0","journal-title":"Hypertens Res"},{"key":"440_CR27","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/aje\/kwf215","volume":"157","author":"JA Hanley","year":"2003","unstructured":"Hanley JA, Negassa A, Edwardes MDdB, Forrester JE. Statistical analysis of correlated data using generalized estimating equations: an orientation. Am J Epidemiol. 2003;157:364\u201375. https:\/\/doi.org\/10.1093\/aje\/kwf215","journal-title":"Am J Epidemiol"},{"key":"440_CR28","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.amjmed.2011.12.013","volume":"125","author":"SH Naderi","year":"2012","unstructured":"Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. Am J Med. 2012;125:882\u20137.e1. https:\/\/doi.org\/10.1016\/j.amjmed.2011.12.013","journal-title":"Am J Med"},{"key":"440_CR29","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1097\/HJH.0000000000001382","volume":"35","author":"AI Kurdi","year":"2017","unstructured":"Kurdi AI, Chen LC, Elliott RA. Exploring factors associated with patients\u2019 adherence to antihypertensive drugs among people with primary hypertension in the United Kingdom. J Hypertens. 2017;35:1881\u201390. https:\/\/doi.org\/10.1097\/HJH.0000000000001382","journal-title":"J Hypertens"},{"key":"440_CR30","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1161\/CIRCULATIONAHA.108.768986","volume":"119","author":"PM Ho","year":"2009","unstructured":"Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119:3028\u201335. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.768986","journal-title":"Circulation"},{"key":"440_CR31","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/S0149-2918(02)80039-X","volume":"24","author":"L Degli Esposti","year":"2002","unstructured":"Degli Esposti L, Esposti ED, Valpiani G, Di Martino M, Saragoni S, Buda S, et al. A retrospective, population-based analysis of persistence with antihypertensive drug therapy in primary care practice in Italy. Clin Ther. 2002;24:1347\u201357. https:\/\/doi.org\/10.1016\/S0149-2918(02)80039-X","journal-title":"Clin Ther"},{"key":"440_CR32","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1097\/MLR.0000000000000515","volume":"54","author":"Z Yang","year":"2016","unstructured":"Yang Z, Howard DH, Loustalot F, Ritchey M, Roy K, Will J. Association of antihypertensive medication adherence with healthcare use and medicaid expenditures for acute cardiovascular events. Med Care. 2016;54:504\u201311.","journal-title":"Med Care"},{"key":"440_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/1753944712470979","volume":"7","author":"CM Ferrario","year":"2013","unstructured":"Ferrario CM, Panjabi S, Buzinec P, Swindle JP. Clinical and economic outcomes associated with amlodipine\/renin\u2013angiotensin system blocker combinations. Ther Adv Cardiovasc Dis. 2013;7:27\u201339. https:\/\/doi.org\/10.1177\/1753944712470979","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"440_CR34","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3122\/jabfm.2007.01.060094","volume":"20","author":"WJ Elliott","year":"2007","unstructured":"Elliott WJ, Plauschinat CA, Skrepnek GH, Gause D. Persistence, adherence, and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapies. J Am Board Fam Med. 2007;20:72\u201380. https:\/\/doi.org\/10.3122\/jabfm.2007.01.060094","journal-title":"J Am Board Fam Med"},{"key":"440_CR35","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1093\/eurjhf\/hfp142","volume":"11","author":"BB Granger","year":"2009","unstructured":"Granger BB, Ekman I, Granger CB, Ostergren J, Olofsson B, Michelson E, et al. Adherence to medication according to sex and age in the CHARM programme. Eur J Heart Fail. 2009;11:1092\u20138. https:\/\/doi.org\/10.1093\/eurjhf\/hfp142","journal-title":"Eur J Heart Fail"},{"key":"440_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-21081-x","volume":"8","author":"J Kim","year":"2018","unstructured":"Kim J, Lee E, Park BJ, Bang JH, Lee JY. Adherence to antiretroviral therapy and factors affecting low medication adherence among incident HIV-infected individuals during 2009-2016: a nationwide study. Sci Rep. 2018;8:1\u20138. https:\/\/doi.org\/10.1038\/s41598-018-21081-x","journal-title":"Sci Rep"},{"key":"440_CR37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4321\/S1886-36552012000400005","volume":"10","author":"L Thunander Sundbom","year":"2012","unstructured":"Thunander Sundbom L, Bingefors K. Women and men report different behaviours in, and reasons for medication non-adherence: a nationwide Swedish survey. Pharm Pract. 2012;10:207\u201321.","journal-title":"Pharm Pract"},{"key":"440_CR38","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.jpsychores.2006.08.003","volume":"61","author":"L Ong","year":"2006","unstructured":"Ong L, Irvine J, Nolan R, Cribbie R, Harris L, Newman D, et al. Gender differences and quality of life in atrial fibrillation: the mediating role of depression. J Psychosom Res. 2006;61:769\u201374. https:\/\/doi.org\/10.1016\/j.jpsychores.2006.08.003","journal-title":"J Psychosom Res"},{"key":"440_CR39","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1161\/CIRCULATIONAHA.110.983874","volume":"123","author":"IM Kronish","year":"2011","unstructured":"Kronish IM, Woodward M, Sergie Z, Ogedegbe G, Falzon L, Mann DM. Meta-Analysis. Circulation. 2011;123:1611\u201321. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.983874","journal-title":"Circulation"},{"key":"440_CR40","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1161\/hypertensionaha.115.05463","volume":"66","author":"G Mancia","year":"2015","unstructured":"Mancia G, Soranna D, Rea F, Ghirardi A, Corrao G, Merlino L. Adherence with antihypertensive drug therapy and the risk of heart failure in clinical practice. Hypertension. 2015;66:742\u20139. https:\/\/doi.org\/10.1161\/hypertensionaha.115.05463","journal-title":"Hypertension"},{"key":"440_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10641963.2018.1465074","volume":"00","author":"T Ishida","year":"2018","unstructured":"Ishida T, Oh A, Hiroi S, Shimasaki Y, Tsuchihashi T. Current prescription status of antihypertensive drugs in Japanese patients with hypertension: analysis by type of comorbidities. Clin Exp Hypertens. 2018;00:1\u20138. https:\/\/doi.org\/10.1080\/10641963.2018.1465074","journal-title":"Clin Exp Hypertens"},{"key":"440_CR42","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1136\/bmj.38803.528113.55","volume":"332","author":"SE McDowell","year":"2006","unstructured":"McDowell SE, Coleman JJ, Ferner RE. Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine. Br Med J. 2006;332:1177\u201380. https:\/\/doi.org\/10.1136\/bmj.38803.528113.55","journal-title":"Br Med J"},{"key":"440_CR43","unstructured":"NHS. Beta blockers\u2014NHS. https:\/\/www.nhs.uk\/conditions\/beta-blockers\/. Accessed 24 June 2019."},{"key":"440_CR44","unstructured":"Harvard Health Publishing. Tips for taking diuretic medications\u2014Harvard Health. https:\/\/www.health.harvard.edu\/heart-health\/tips-for-taking-diuretic-medications. Accessed 24 June 2019."},{"key":"440_CR45","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1097\/MLR.0b013e31829b1d2a","volume":"51","author":"MA Raebel","year":"2013","unstructured":"Raebel MA, Schmittdiel J, Karter AJ, Konieczny JL, Steiner JF. Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases. Med Care. 2013;51:S11\u201321. https:\/\/doi.org\/10.1097\/MLR.0b013e31829b1d2a","journal-title":"Med Care"},{"key":"440_CR46","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0895-4356(96)00268-5","volume":"50","author":"JF Steiner","year":"1997","unstructured":"Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50:105\u201316. https:\/\/doi.org\/10.1016\/S0895-4356(96)00268-5","journal-title":"J Clin Epidemiol"},{"key":"440_CR47","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/hepr.12497","volume":"45","author":"M Ohisa","year":"2015","unstructured":"Ohisa M, Kimura Y, Matsuo J, Akita T, Sato T, Matsuoka T, et al. Estimated numbers of patients with liver disease related to hepatitis B or C virus infection based on the database reconstructed from medical claims from 2008 to 2010 in Japan. Hepatol Res. 2015;45:1228\u201340. https:\/\/doi.org\/10.1111\/hepr.12497","journal-title":"Hepatol Res"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41440-020-0440-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-020-0440-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-020-0440-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:24:20Z","timestamp":1684617860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-020-0440-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,20]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["440"],"URL":"https:\/\/doi.org\/10.1038\/s41440-020-0440-2","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,20]]},"assertion":[{"value":"15 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"HK, SK, and HM are affiliated with the Department of Healthcare Quality Assessment at the University of Tokyo. The department is a social collaboration department supported by the National Clinical Database, Johnson & Johnson K.K., and Nipro Corporation. SK reports investigator-initiated grant funding from Bayer and Daiichi Sankyo, and personal fees from AstraZeneca, Bayer, Bristol-Myers Squibb, Daiichi Sankyo, Pfizer, Teikoku Seiyaku, and Boehringer Ingelheim, outside the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}